BioStem Technologies, Inc. (BSEM) Operating margin 2024–2025
BioStem Technologies, Inc. (BSEM) operating margin by fiscal year — reported operating income divided by reported revenue.
-1.5%FY2025 · since FY2024: 44.7% → -1.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1.5% | -46.1 pp |
| FY2024 | 44.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BSEM financial trends
BSEM RevenueBSEM Net incomeBSEM Net marginBSEM Gross profitBSEM Gross marginBSEM Operating incomeBSEM Operating cash flowBSEM Free cash flowBSEM Capital expendituresBSEM Return on equityBSEM Stock buybacksBSEM Dividends paidBSEM Total assetsBSEM Total liabilitiesBSEM Shareholders’ equityBSEM overview →